James T. Parsons

Companies

• Oncolytics BiotechBoard member Jan 2, 2026 to now¹
• DiaMedica Therapeutics Inc.Board member Dec 6, 2018 to now²
• Trillium Therapeutics Inc.Chief financial officer Jan 4, 2021 to Nov 19, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• DTDiaMedica Therapeutics Inc. DMAC97,949 shares⁴$779.7K at $7.96Jan 2, 2026
• OBOncolytics Biotech ONCY41,849 shares⁵$21.0K at $0.50Mar 11, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 11, 2026Bought 10,000 shares at $1.03 of Oncolytics Biotech⁵
• Jan 2, 2026Granted 10,095 shares at $8.42 of DiaMedica Therapeutics Inc.⁴
• Nov 21, 2025Exercised options 12,000 shares at $2.20 of DiaMedica Therapeutics Inc.⁶
• Jan 2, 2025Granted 15,917 shares at $5.34 of DiaMedica Therapeutics Inc.⁷
• Jan 2, 2024Granted 21,428 shares at $2.80 of DiaMedica Therapeutics Inc.⁸
• Jan 3, 2022Granted 16,773 shares at $3.58 of DiaMedica Therapeutics Inc.⁹